PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$64.10 USD
+0.28 (0.44%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $64.10 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth B Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Prestige Consumer Healthcare Inc. has a PEG ratio of 2.00 compared to the Medical - Products industry's PEG ratio of 2.31.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PBH 64.10 +0.28(0.44%)
Will PBH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PBH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PBH
Prestige Consumer Healthcare (PBH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Prestige Consumer Healthcare (PBH) Misses Q1 Earnings and Revenue Estimates
PBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stay Ahead of the Game With Prestige Consumer Healthcare (PBH) Q1 Earnings: Wall Street's Insights on Key Metrics
AdaptHealth Corp. (AHCO) Lags Q2 Earnings and Revenue Estimates
Why Prestige Consumer Healthcare (PBH) is a Top Value Stock for the Long-Term
Other News for PBH
Is PBH heading for a slide? Lower Bollinger Band Walk shows up after advancing 0.98%
Tracking John Rogers' Ariel Investments Portfolio - Q2 2025 Update
Is PBH primed for volatility? NR7 shows up after advancing 0.37%
betr Entertainment Advances Takeover Bid for PointsBet Holdings
Is PBH positioned for a breakdown? New 52 Week Closing Low shows up after sliding 0.44%